Task Force Again Recommends Cervical Cancer Screening

A federal task force has again recommended that all women between the ages of 21 and 65 receive a screening for cervical cancer as often as every 3 years.

The US Preventive Services Task Force (USPSTF) has concludedthat in women between 21 and 29, the benefits of screening for cervical cancer using a Pap smear every 3 years outweighs the potential harms. For women aged 30 to 65, the USPSTF recommends screening via a Pap smear every 3 years, or HPV (human papillomavirus) testing every 5 years or with both tests, also every 5 years.

Screening women older than 65 who have had screening in the past and women under age 21 does not show any benefit, according to the task force. Also, screening is not recommended in women who have had a hysterectomy that included removing the cervix and don’t have a history or high-grade precancerous lesion or cervical cancer.

In 2012, the USPSTF made the same recommendations.

HPV accounts for over 90% of cervical cancers. The task force notes that screening and treatment for precancerous lesions help explain why the US has a low cervical cancer death rate of only 2.3 deaths per 100,000 women.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement